Screen Readers Skip to Content
Tweet Facebook Buffer

Many People with HIV Start Treatment Too Late

Author: Infectious Diseases Society of America(i)

Published: 2010-05-29 : (Rev. 2018-01-26)

Synopsis:

The earlier people are diagnosed with HIV and get access to care the better their clinical outcomes.

Main Digest

Study highlights need for earlier diagnosis and treatment - Despite growing evidence that the earlier people are diagnosed with HIV and get access to care, the better their clinical outcomes, many HIV-infected people in the United States and Canada are not receiving the care they need early enough.

A study of nearly 45,000 patients in both countries highlighting this trend appears in the June 1, 2010, issue of Clinical Infectious Diseases, now available online (www.journals.uchicago.edu/doi/abs/10.1086/652650).

Researchers analyzed patients' CD4 cell counts, a critical measure of immune system strength, when these patients first began clinical care for HIV from 1997 to 2007.

Although the median CD4 count at first presentation increased annually over this period, from 256 cells/mm3 to 317 cells/mm3, it remains below the level currently recommended for patients to start anti-retroviral therapy, 350 cells/mm3. The median age at which patients first received HIV care increased over the study period from 40 to 43 years of age.

"The public health implications of our findings are clear: Delayed diagnosis reduces survival, and individuals enter into HIV care with lower CD4 counts than the guidelines for anti-retroviral therapy initiation," said study author Richard Moore, MD, of Johns Hopkins University School of Medicine.

"A delay in presentation for treatment not only increases the chance of clinical disease progression but also increases the risk of ongoing transmission."

In an accompanying editorial, Cynthia Gay, MD, of the University of North Carolina at Chapel Hill, agreed:

"These findings reveal that despite such compelling data, there is much room for improving our ability to link more HIV-infected individuals with effective treatment prior to immunological deterioration."

Founded in 1979, Clinical Infectious Diseases publishes clinical articles twice monthly in a variety of areas of infectious disease, and is one of the most highly regarded journals in this specialty.

It is published under the auspices of the Infectious Diseases Society of America (IDSA).

Based in Arlington, Va., IDSA is a professional society representing more than 9,000 physicians and scientists who specialize in infectious diseases.

The HIV Medicine Association (HIVMA), nested within IDSA, is the professional home for more than 3,800 physicians, scientists, and other health care professionals dedicated to the field of HIV/AIDS.

For more information, visit our websites: www.idsociety.org and www.hivma.org

(i)Source/Reference: Infectious Diseases Society of America. Disabled World makes no warranties or representations in connection therewith. Content may have been edited for style, clarity or length.

Related Documents


Important:

Disabled World uses cookies to help provide and enhance our services to you and tailor some content and advertising. By continuing you agree to the Disabled World Cookie Policy, Privacy Policy and Terms of Service.

Disabled World is strictly a news and information website provided for general informational purpose only and does not constitute medical advice. Materials presented are in no way meant to be a substitute for professional medical care by a qualified practitioner, nor should they be construed as such. Any 3rd party offering or advertising on disabled-world.com does not constitute endorsement by Disabled World.

Please report outdated or inaccurate information to us.